Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00417911
Recruitment Status : Completed
First Posted : January 4, 2007
Last Update Posted : June 22, 2010
Janssen-Cilag Ltd.
Information provided by:
Nordic Myeloma Study Group